PuraMed BioScience

Puramed Bioscience, Inc. engages in the development and marketing of non-prescription medicinal and healthcare products. Its principal products include LipiGesic M, which provides acute relief from migraine headaches; and LipiGesic PM that provides remedy for insomnia and other sleep disorders. The company’s other products comprise LipiGesic H for common tension headaches; LipiGesic Smoker’s Pal, which provides relief from the symptoms associated with nicotine withdrawal; LipiGesic RLS for problematic leg cramps associated with Restless Leg Syndrome; LipiGesic GI that provides relief for symptoms associated with nighttime reflux disorders; and LipiGesic CS for canker sore outbreaks. Puramed Bioscience was founded in 2006 and is based in Schofield, Wisconsin. The Company began trading under the symbol “PMBS” in May 2008.